US Patent Litigations are now available. Check here

EP2661276

REVANCE THERAPEUTICS
Application Number
EP11855190A
Filing Date
Dec 22, 2011
Status
Revoked
Sep 22, 2023
Grant Date
Aug 2, 2017
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP2661276B1 was granted on Aug 2, 2017 by Revance Therapeutics The patent is currently Revoked.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionDE102006019447
N/A
OppositionWO2005084410
N/A
OppositionUS2008220021
N/A
OppositionWO2010151840
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.